Differences between Candesartan and Hydralazine in the protection of penile structures in spontaneously hypertensive rats

Journal of Sexual Medicine

Volumn 3, Issue 4, 2006, Pages 604-611

  Mazza, Osvaldo Néstor ^a   Angerosa, Margarita ^a   Becher, Edgardo ^a   Toblli, Jorge Eduardo ^a  

^a HOSPITAL ALEMÁN   (Argentina)

Author keywords

Candesartan; Corpus cavernous; Erectile dysfunction; Spontaneously hypertensive rats; Vasodilatation

Indexed keywords

ACETYLCHOLINE; CANDESARTAN HEXETIL; COLLAGEN TYPE 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDRALAZINE; VASODILATOR AGENT;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; CONTROLLED STUDY; CORPUS CAVERNOSUM; ERECTILE DYSFUNCTION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MORPHOMETRICS; NONHUMAN; PENIS ERECTION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SMOOTH MUSCLE RELAXATION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 33745238364     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2006.00235.x     Document Type: Article

References (24)

1. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460-3.
2. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328-38.
3. Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A, de la Taille A, Hayek OR, Shabsigh R. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164: 1188-91.
4. Burchardt M, Burchardt T, Anastasiadis AG, Kiss AJ, Shabsigh A, de La Taille A, Pawar RV, Baer L, Shabsigh R. Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension. Int J Impot Res 2001; 13: 276-81.
5. Bansal TC, Guay AT, Jacobson J, Woods BO, Nesto RW. Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction. J Sex Med 2005; 2: 96-103.
6. Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R. Erectile dysfunction is a marker for cardiovascular disease: Results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2005; 2:40-52.
7. Behr-Roussel D, Chamiot-Clerc P, Bernabe J, Mevel K, Alexandre L, Safar ME, Giuliano F. Erectile dysfunction in spontaneously hypertensive rats: Pathophysiological mechanisms. Am J Physiol Regul Integr Comp Physiol 2003; 284: R682-8.
8. Behr-Roussel D, Gorny D, Mevel K, Compagnie S, Kern P, Sivan V, Bernabe J, Bedigian MP, Alexandre L, Giuliano F. Erectile dysfunction: An early marker for hypertension? A longitudinal study in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2005; 288:R276-83.
9. Toblli JE, Stella I, Inserra F, Ferder L, Zeller FL, Mazza ON. Morphologic changes in cavernous tissue in spontaneously hypertensive rats. Am J Hypertens 2000; 13: 686-92.
10. Chitaley K, Webb RC, Dorrance AM, Mills TM. Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats. Int J Impot Res 2001;(suppl 5): S16-20.
11. Park JK, Kim SZ, Kim SH, Park YK, Cho KW. Renin angiotensin system in rabbit corpus cavernosum: Functional characterization of angiotensin II receptors. J Urol 1997; 158:653-8.
12. Toblli JE, Stella I, Nestor Mazza O, Ferder L, Inserra F. Protection of cavernous tissue in male spontaneously hypertensive rats: Beyond blood pressure control. Am J Hypertens 2004; 17: 516-22.
13. Toblli JE, Stella I, Mazza ON, Ferder L, Inserra F. Candesartan cilexetil protects cavernous tissue in spontaneously hypertensive rats. Int J Impot Res 2004; 16: 305-12.
14. Toblli JE, Stella I, Mazza ON, Ferder L, Inserra F. Different effect of losartan and amlodipine on penile structures in male spontaneously hypertensive rats. Am J Nephrol 2004; 24: 614-23.
15. Llisterri JL, Lozano Vidal JV, Aznar Vicente J, Argaya Roca M, Pol Bravo C, Sanchez Zamorano MA, Ferrario CA. Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 2001; 321: 336-41.
16. Fogari R, Preti P, Derosa G, Marasi G, Zoppi A, Rinaldi A, Mugellini A. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 2002; 58: 177-80.
17. Adams MA, Banting JD, Maurice DH, Morales A, Heaton JP. Vascular control mechanisms in penile erection: Phylogeny and the inevitability of multiple and overlapping systems. Int J Impot Res 1997; 9: 85-91.
18. Azadzoi KM, Siroky MB, Goldstein I. Study of etiologic relationship of arterial atherosclerosis to corporal veno-occlusive dysfunction in the rabbit. J Urol 1996; 155: 1795-800.
19. Azadzoi KM, Goldstein I, Siroky MB. Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model. J Urol 1997; 157: 1011-7.
20. Ushiyama M, Morita T, Kuramochi T, Yagi S, Katayama S. Erectile dysfunction in hypertensive rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide. Hypertens Res 2004; 27: 253-61.
21. Demirci B, McKeown PP, Bayraktutan U. Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects. J Hypertens 2005; 23: 2219-27.
22. Brosnan MJ, Hamilton CA, Graham D, Lygate CA, Jardine E, Dominiczak AF. Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats. J Hypertens 2002; 20: 281-6.
23. Yao L, Kobori H, Rahman M, Seth DM, Shokoji T, Fan Y, Zhang GX, Kimura S, Abe Y, Nishiyama A. Olmesartan improves endothelin-induced hypertension and oxidative stress in rats. Hypertens Res 2004; 27: 493-500.
24. Toblli JE, DeRosa G, Cao G, Piorno P, Pagano P. ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats. Kidney Int 2004; 65: 2343-59.